Annual EBITDA
$1.11B$13.60M-1.21%
Summary
- Current Value
- As of today, COO annual EBITDA is $1.11B, down -1.21% on
- Historical Performance
- COO annual EBITDA is up +18.99% over the past 3 years, up +68.15% over the past 5 years
- All-Time High Comparison
- COO annual EBITDA is currently -1.21% below its historical high of $1.12B set on
- 3-Year Low Comparison
- COO annual EBITDA is +21.66% above its 3-year low of $909.00M reached on
- Sector Comparison
- COO annual EBITDA is higher than 93.67% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.11B | -1.2% | +19.0% | +68.2% | +264.7% | |
| Quarterly EBITDA | $308.30M | +12.9% | +28.9% | +45.1% | +320.6% | |
| TTM EBITDA | $1.10B | -0.8% | +17.1% | +65.4% | +265.9% | |
| Price | $71.52 | -9.6% | -11.9% | -24.0% | +314.7% | |
| PE Ratio | 35.40 | -7.4% | -17.6% | +325.5% | +51.4% | |
| Annual Revenue | $4.09B | +5.1% | +23.7% | +68.3% | +251.6% | |
| Annual EPS | $1.87 | -4.2% | -3.4% | +56.0% | +208.6% | |
| $745.20M | +5.6% | +35.2% | +120.4% | +256.1% | ||
| Annual Net Income | $374.90M | -4.4% | -2.8% | +57.3% | +232.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.12B | -1.2% | |
| 5Y | $1.12B | -1.2% | |
| All | $1.12B | -1.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $909.00M | +21.7% | |
| 5Y | $657.70M | N/A | +68.2% |
| All | -$28.19M | +4023.7% |
EBITDA History
FAQ
What is the current annual EBITDA of COO?
As of today, COO annual EBITDA is $1.11B
What is 1-year change in COO annual EBITDA?
COO annual EBITDA is down -1.21% year-over-year
What is 3-year change in COO annual EBITDA?
COO annual EBITDA is up +18.99% over the past 3 years
How far is COO annual EBITDA from its all-time high?
COO annual EBITDA is currently -1.21% below its historical high of $1.12B set on October 31, 2024
How does COO annual EBITDA rank versus sector peers?
COO annual EBITDA is higher than 93.67% of companies in Healthcare sector
When is COO next annual earnings release?
As of today, the next annual earnings release for COO has not been scheduled
Quarterly EBITDA
$308.30M$69.50M+29.10%
Summary
- Current Value
- As of today, COO quarterly EBITDA is $308.30M, up +29.10% on
- Historical Performance
- COO quarterly EBITDA is up +12.93% year-over-year, up +28.89% over the past 3 years
- All-Time High Comparison
- COO quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- COO quarterly EBITDA is +64.78% above its 3-year low of $187.10M reached on
- Sector Comparison
- COO quarterly EBITDA is higher than 93.51% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $308.30M | +29.1% | +12.9% | +28.9% | +45.1% | |
| Annual EBITDA | $1.11B | – | -1.2% | +19.0% | +68.2% | |
| TTM EBITDA | $1.10B | +3.3% | -0.8% | +17.1% | +65.4% | |
| Price | $71.52 | -12.9% | -9.6% | -11.9% | -24.0% | |
| PE Ratio | 35.40 | -19.2% | -7.4% | -17.6% | +325.5% | |
| Quarterly Revenue | $1.02B | -3.9% | +6.2% | +19.3% | +50.5% | |
| Quarterly EPS | $0.67 | +55.7% | +28.3% | +56.3% | -93.7% | |
| $214.60M | +52.9% | +17.9% | +43.5% | +56.6% | ||
| Quarterly Net Income | $130.80M | +54.6% | +25.4% | +54.6% | -93.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $308.30M | at high | |
| 3Y | $308.30M | at high | |
| 5Y | $308.30M | at high | |
| All | $308.30M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $238.80M | +29.1% | |
| 3Y | $187.10M | +64.8% | |
| 5Y | $187.10M | +64.8% | |
| All | -$428.30M | +172.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of COO?
As of today, COO quarterly EBITDA is $308.30M
What is COO quarterly EBITDA most recent change?
COO quarterly EBITDA was up +29.10% on January 31, 2026
What is 1-year change in COO quarterly EBITDA?
COO quarterly EBITDA is up +12.93% year-over-year
How far is COO quarterly EBITDA from its all-time high?
COO quarterly EBITDA is currently at its all-time high
How does COO quarterly EBITDA rank versus sector peers?
COO quarterly EBITDA is higher than 93.51% of companies in Healthcare sector
When is COO next earnings release?
The next earnings release for COO is on
TTM EBITDA
$1.10B$35.30M+3.33%
Summary
- Current Value
- As of today, COO TTM EBITDA is $1.10B, up +3.33% on
- Historical Performance
- COO TTM EBITDA is down -0.75% year-over-year, up +17.14% over the past 3 years
- All-Time High Comparison
- COO TTM EBITDA is currently -2.29% below its historical high of $1.12B set on
- 3-Year Low Comparison
- COO TTM EBITDA is +24.16% above its 3-year low of $882.40M reached on
- Sector Comparison
- COO TTM EBITDA is higher than 93.42% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.10B | +3.3% | -0.8% | +17.1% | +65.4% | |
| Annual EBITDA | $1.11B | – | -1.2% | +19.0% | +68.2% | |
| Quarterly EBITDA | $308.30M | +29.1% | +12.9% | +28.9% | +45.1% | |
| Price | $71.52 | -12.9% | -9.6% | -11.9% | -24.0% | |
| PE Ratio | 35.40 | -19.2% | -7.4% | -17.6% | +325.5% | |
| TTM Revenue | $4.15B | +1.4% | +5.7% | +22.8% | +68.4% | |
| TTM EPS | $2.02 | +7.8% | -2.3% | +7.0% | -82.1% | |
| $715.50M | +4.8% | -2.6% | +30.3% | +93.1% | ||
| TTM Net Income | $401.40M | +7.1% | -3.4% | +7.0% | -82.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.12B | -2.3% | |
| 3Y | $1.12B | -2.3% | |
| 5Y | $1.12B | -2.3% | |
| All | $1.12B | -2.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.06B | +3.3% | |
| 3Y | $882.40M | +24.2% | |
| 5Y | $662.50M | N/A | +65.4% |
| All | -$388.90M | +381.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of COO?
As of today, COO TTM EBITDA is $1.10B
What is COO TTM EBITDA most recent change?
COO TTM EBITDA was up +3.33% on January 31, 2026
What is 1-year change in COO TTM EBITDA?
COO TTM EBITDA is down -0.75% year-over-year
How far is COO TTM EBITDA from its all-time high?
COO TTM EBITDA is currently -2.29% below its historical high of $1.12B set on April 30, 2025
How does COO TTM EBITDA rank versus sector peers?
COO TTM EBITDA is higher than 93.42% of companies in Healthcare sector
When is COO next earnings release?
The next earnings release for COO is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- COO Official Website www.coopercos.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/711404/000162828026015620/0001628280-26-015620-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/711404/000162828025055615/0001628280-25-055615-index.htm
- COO Profile on Yahoo Finance finance.yahoo.com/quote/COO
- COO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coo